|
Figure 4.
FIGURE 4. Schematic diagram showing hydrogen-bond and
salt-bridge interactions of the active-site residues. Putative
interactions are shown by dotted lines if the acceptor and donor
are less than 3.5 Å apart. The hydrogen bonds associated
with the phosphate group of PLP are omitted for clarity. A,
hBCATc-ox complexed with gabapentin. B, hBCATc-ox complexed with
4MeVA.
|